R9-13
R9-13 is a fatty acid-conjugated relaxin and an agonist of LGR7 (RXFP1). R9-13 induces sustained pubic symphysis elongation in estrogen-pretreated mice. R9-13 exhibits long-acting pharmacokinetic profiles in rodents, with in vivo activity lasting up to one week after administration. R9-13 can be used in studies related to acute heart failure.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- 화학식: C294H478N78O83S9
- 분자량:6722.00
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:CD1 (female; estrogen-primed)[1]
-
Dosage:0.9, 3.0, 9, 30 nmol/kg; 1, 10, 30 nmol/kg
-
Administration:single dose; measured at 168 h after treatment
-
Result:Observed dose-responsive pubic ligament elongation at 24 hours post-dosing; sustained elongation effect at 168 hours post-dosing.
Chemical Information
-
분자량 6722.00
-
화학식 C294H478N78O83S9
-
Sequence
Chain1:{pGln}-Cys(carbamic acid-PEG2-carbamic acid-PEG2-Lys-C18diacid)-Tyr-Ser-Ala-Leu-Ala-Asn-Lys-Cys-Cys-His-Val-Gly-Cys-Ile-Lys-Arg-Ser-Leu-Ala-Arg-Phe-Cys; Chain2:Ala-Ser-Trp-Met-Glu-Glu-Val-Ile-Lys-Leu-Cys-Gly-Arg-Glu-Leu-Val-Arg-Ala-Gln-Ile-Ala-Ile-Cys-Gly-Met-Ser-Thr-Trp-Ser (Disulfidebridge:Chain 1 Cys10-Chain 1 Cys15,Chain 1 Cys11-Chain 2 Cys11,Chain 1 Cys24-Chain 2 Cys23
-
Sequence Shortening
Chain1:{pGln}-Cys(carbamic acid-PEG2-carbamic acid-PEG2-Lys-C18diacid)-YSALANKCCHVGCIKRSLARFC; Chain2:ASWMEEVIKLCGRELVRAQIAICGMSTWS (Disulfidebridge:Chain 1 Cys10-Chain 1 Cys15,Chain 1 Cys11-Chain 2 Cys11,Chain 1 Cys24-Chain 2 Cys23
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)